Anabel Sorolla
Anabel Sorolla
Miguel Servet Fellow at the IRBLleida
Потвърден имейл адрес: irblleida.cat
Distinction between active and passive targeting of nanoparticles dictate their overall therapeutic efficacy
TD Clemons, R Singh, A Sorolla, N Chaudhari, A Hubbard, KS Iyer
Langmuir 34 (50), 15343-15349, 2018
An ENU mutagenesis screen identifies novel and known genes involved in epigenetic processes in the mouse
L Daxinger, SK Harten, H Oey, T Epp, L Isbel, E Huang, N Whitelaw, ...
Genome biology 14 (9), 1-17, 2013
Antioxidants block proteasome inhibitor function in endometrial carcinoma cells
D Llobet, N Eritja, M Encinas, A Sorolla, A Yeramian, JA Schoenenberger, ...
Anti-cancer drugs 19 (2), 115-124, 2008
CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells
D Llobet, N Eritja, M Encinas, N Llecha, A Yeramian, J Pallares, A Sorolla, ...
Oncogene 27 (18), 2513-2524, 2008
Waking up dormant tumor suppressor genes with zinc fingers, TALEs and the CRISPR/dCas9 system
B Garcia-Bloj, C Moses, A Sgro, J Plani-Lam, M Arooj, C Duffy, ...
Oncotarget 7 (37), 60535, 2016
Functional expression of voltage‐gated calcium channels in human melanoma
A Das, C Pushparaj, N Bahí, A Sorolla, J Herreros, R Pamplona, R Vilella, ...
Pigment cell & melanoma research 25 (2), 200-212, 2012
Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer
C Duffy, A Sorolla, E Wang, E Golden, E Woodward, K Davern, D Ho, ...
NPJ precision oncology 4 (1), 1-16, 2020
The multikinase inhibitor Sorafenib induces apoptosis and sensitises endometrial cancer cells to TRAIL by different mechanisms
D Llobet, N Eritja, A Yeramian, J Pallares, A Sorolla, M Domingo, ...
European Journal of Cancer 46 (4), 836-850, 2010
Inhibition of activated receptor tyrosine kinases by Sunitinib induces growth arrest and sensitizes melanoma cells to Bortezomib by blocking Akt pathway
A Yeramian, A Sorolla, A Velasco, M Santacana, X Dolcet, J Valls, L Abal, ...
International journal of cancer 130 (4), 967-978, 2012
Effect of proteasome inhibitors on proliferation and apoptosis of human cutaneous melanoma‐derived cell lines
A Sorolla, A Yeramian, X Dolcet, AM Perez de Santos, D Llobet, ...
British Journal of Dermatology 158 (3), 496-504, 2008
Precision medicine by designer interference peptides: applications in oncology and molecular therapeutics
A Sorolla, E Wang, E Golden, C Duffy, ST Henriques, AD Redfern, ...
Oncogene 39 (6), 1167-1184, 2020
Tumor penetrating peptides inhibiting MYC as a potent targeted therapeutic strategy for triple-negative breast cancers
E Wang, A Sorolla, PT Cunningham, HM Bogdawa, S Beck, E Golden, ...
Oncogene 38 (1), 140-150, 2019
Nuclear factor-κB2/p100 promotes endometrial carcinoma cell survival under hypoxia in a HIF-1α independent manner
A Yeramian, M Santacana, A Sorolla, D Llobet, M Encinas, A Velasco, ...
Laboratory investigation 91 (6), 859-871, 2011
Blockade of NFκB activity by sunitinib increases cell death in bortezomib-treated endometrial carcinoma cells
A Sorolla, A Yeramian, J Valls, X Dolcet, L Bergadà, A Llombart-Cussac, ...
Molecular oncology 6 (5), 530-541, 2012
Loss of heterozygosity in endometrial carcinoma
A Velasco, J Pallares, M Santacana, A Yeramian, X Dolcet, N Eritja, ...
International journal of gynecological pathology 27 (3), 305-317, 2008
Triple-hit therapeutic approach for triple negative breast cancers using docetaxel nanoparticles, EN1-iPeps and RGD peptides
A Sorolla, E Wang, TD Clemons, CW Evans, JHC Plani-Lam, E Golden, ...
Nanomedicine: Nanotechnology, Biology and Medicine 20, 102003, 2019
Tumour suppression by targeted intravenous non-viral CRISPRa using dendritic polymers
JA Kretzmann, CW Evans, C Moses, A Sorolla, AL Kretzmann, E Wang, ...
Chemical science 10 (33), 7718-7727, 2019
Sensitizing basal-like breast cancer to chemotherapy using nanoparticles conjugated with interference peptide
BP Sorolla A, Ho D, Wang E, Evans CW, Ormonde CF, Rashwan R, Singh R, Iyer KS
Nanoscale 8 (17), 9343-53, 2016
From seabed to bedside: A review on promising marine anticancer compounds
E Wang, MA Sorolla, PD Gopal Krishnan, A Sorolla
Biomolecules 10 (2), 248, 2020
New therapeutic targets in melanoma
RM Martí, A Sorolla, A Yeramian
Actas Dermo-Sifiliográficas (English Edition) 103 (7), 579-590, 2012
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20